Aurobindo Pharma, a mid-size pharmaceutical company, witnessed a rise in share price on Wednesday after its USA subsidiary emerged as the highest bidder for acquisition of nutritional supplement maker, Natrol and other affiliate entities ('Natrol'). The acquisition is under a process to be finally approved by the United States Bankruptcy Court for the District of Delaware.

Under the auction process, Aurobindo USA emerged as the highest and best bidder with a bid of USD 132.5 million to acquire the assets of Natrol with an agreement to take on certain liabilities.

Shares of the company are trading at Rs 1,063.90, up Rs 35.8, or 3.48% at the Bombay Stock Exchange (BSE) on Wednesday at 10:51 a.m.

The scrip has touched an intra-day high of Rs 1,067.60 and low of Rs 1,028. The total volume of shares traded at the BSE is 65,422.